<DOC>
	<DOC>NCT02019433</DOC>
	<brief_summary>Implant Survival as well as clinical and radiological Follow-Up of acetabular Titan-Augment Structan®</brief_summary>
	<brief_title>Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®</brief_title>
	<detailed_description />
	<criteria>Minimum age 18 years Indication for cementless hip arthroplasty with acetabular defects that need Allograft or titanium augment Patient consent for study participation Physical and mental willingness to participate in the followups Patient not available for followup Increased anesthetics risks for the patient according to the "American Society of Anesthesiology": ASA IV Tumor Alcohol or Drug abuse Permanent cortisone therapy Clinically relevant infection (Planned) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>THA, augment, revision, pelvis</keyword>
</DOC>